Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease | Zendy

Ladan Zand | Zendy; Vicente E. Torres | Zendy; Timothy S. Larson | Zendy; Bernard F. King | Zendy; Sanjeev Sethi | Zendy; Eric J. Bergstralh | Zendy; Andrea Angioi | Zendy; Fernando C. Fervenza | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease

Author(s) -

Ladan Zand,

Vicente E. Torres,

Timothy S. Larson,

Bernard F. King,

Sanjeev Sethi,

Eric J. Bergstralh,

Andrea Angioi,

Fernando C. Fervenza

Publication year - 2015

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfv394

Subject(s) - medicine , hemodynamics , polycystic kidney disease , hmg coa reductase , kidney , autosomal dominant polycystic kidney disease , endocrinology , disease , kidney disease , urology , hydroxymethylglutaryl coa reductase , reductase , renal circulation , cardiology , renal blood flow , enzyme , biochemistry , chemistry

To determine the effect of statins on renal hemodynamics in normal volunteers and those with autosomal dominant polycystic kidney disease either with mild or moderate renal dysfunction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research